BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26537525)

  • 1. The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.
    Snider JT; Goldman DP; Rosenblatt L; Seekins D; Juday T; Sanchez Y; Wu Y; Peneva D; Romley JA
    Med Care Res Rev; 2016 Jun; 73(3):329-48. PubMed ID: 26537525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State AIDS Drug Assistance Programs: equity and efficiency in an era of rapidly changing treatment standards.
    Johri M; David Paltiel A; Goldie SJ; Freedberg KA
    Med Care; 2002 May; 40(5):429-41. PubMed ID: 11961477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of state policy on the costs of HIV infection.
    Goldman DP; Bhattacharya J; Leibowitz AA; Joyce GF; Shapiro MF; Bozzette SA
    Med Care Res Rev; 2001 Mar; 58(1):31-53; discussion 54-9. PubMed ID: 11236232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perspectives. Need for access to new drugs creates big challenge for state ADAP programs (AIDS Drug Assistance Programs); better coordination with Medicaid urged.
    Cunningham R
    Med Health; 1999 Mar; 53(11):suppl 1-4. PubMed ID: 10346194
    [No Abstract]   [Full Text] [Related]  

  • 5. Financial Barriers and Lapses in Treatment and Care of HIV-Infected Adults in a Southern State in the United States.
    Wohl DA; Kuwahara RK; Javadi K; Kirby C; Rosen DL; Napravnik S; Farel C
    AIDS Patient Care STDS; 2017 Nov; 31(11):463-469. PubMed ID: 29039984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eligibility policies for the state AIDS drug assistance programs.
    Buchanan RJ; Chakravorty BJ; Smith SR
    Soc Work Health Care; 2001; 32(3):81-104. PubMed ID: 11358274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virginia votes to increase funds for drug aid, insurance subsidy.
    AIDS Policy Law; 1999 Mar; 14(5):10-1. PubMed ID: 11366443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some gains seen in ADAP access, but big problems remain.
    AIDS Policy Law; 1998 Mar; 13(4):6-7. PubMed ID: 11365163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of zidovudine-based triple combination therapy on an AIDS drug assistance program.
    Mauskopf JA; Tolson JM; Simpson KN; Pham SV; Albright J
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):302-13. PubMed ID: 10836752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facilitators and Barriers: Clients' Perspective on the Virginia AIDS Drug Assistance Program's Affordable Care Act Implementation.
    McManus KA; Debolt C; Elwood S; Saint-Surin T; Winstead-Derlega C; Brennan RO; Dillingham R; Flickinger TE
    AIDS Res Hum Retroviruses; 2019 Aug; 35(8):734-745. PubMed ID: 31146536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S.
    Kahn JG; Zhang X; Cross LT; Palacio H; Birkhead GS; Morin SF
    Public Health Rep; 2002; 117(3):252-62; discussion 231-2. PubMed ID: 12432136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the need to reform the US AIDS Drug Assistance Program.
    Whigham MR
    J Int Assoc Physicians AIDS Care; 1998 Jan; 4(1):39-40. PubMed ID: 11365032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative study of underutilization of the AIDS drug assistance program.
    Olson KM; Godwin NC; Wilkins SA; Mugavero MJ; Moneyham LD; Slater LZ; Raper JL
    J Assoc Nurses AIDS Care; 2014; 25(5):392-404. PubMed ID: 24503498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPACA and Low-Income People Living with HIV: 2014 Qualified Health Plan Enrollment in a Medicaid Nonexpansion State.
    McManus KA; McGonigle KM; Engelhard CL; Dillingham R
    South Med J; 2016 Jun; 109(6):371-7. PubMed ID: 27255096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More States are expanding Medicaid reimbursement for poor HIV patients.
    AIDS Alert; 2000 Jan; 15(1):1-3. PubMed ID: 11366356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing resource allocation in United States AIDS drug assistance programs.
    Linas BP; Zheng H; Losina E; Rockwell A; Walensky RP; Cranston K; Freedberg KA
    Clin Infect Dis; 2006 Nov; 43(10):1357-64. PubMed ID: 17051505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Location strongest factor in getting ADAP help.
    AIDS Alert; 2001 May; 16(5):57-8, 53. PubMed ID: 11590779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The economics of effective AIDS treatment in Thailand.
    Over M; Revenga A; Masaki E; Peerapatanapokin W; Gold J; Tangcharoensathien V; Thanprasertsuk S
    AIDS; 2007 Jul; 21 Suppl 4():S105-16. PubMed ID: 17620745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The promise of ADAP.
    Montgomery M
    Focus; 2007 Jan; 22(1):4-6. PubMed ID: 17526106
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of visa status and Medicare eligibility on people diagnosed with HIV in Western Australia: a qualitative report.
    Herrmann S; Wardrop J; John M; Gaudieri S; Lucas M; Mallal S; Nolan D
    Sex Health; 2012 Nov; 9(5):407-13. PubMed ID: 22950904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.